M&A TRANSACTION · 2024
Infusion Associates acquired by Vivo Infusion
$215.0M· 14.3x EBITDA
Target
Infusion Associates
Acquirer
Vivo Infusion
Strategic buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$15.0M
Deal Value
$215.0M
EV/EBITDA
14.3x
Context
This $215.0M acquisition of Infusion Associates by Vivo Infusion sits in the pharmacy sub-vertical. The 14.3x EBITDA multiple paid in 2024 can be compared against the population median for pharmacy transactions of similar size on our Pharmacy valuation hub. Vivo Infusion is acquiring as a strategic buyer; see how strategic acquirers typically price pharmacy businesses on our Pharmacy strategic buyer-pool page.
Source
Data sourced from Press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own pharmacy
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Infusion Associates acquisition.